2 min read

Revolve Healthcare named among Europe’s fastest-growing healthcare companies

We’re proud to share that Revolve Healthcare has been recognised as one of the fastest-growing healthcare companies in Europe, according to the FT1000 ranking by the Financial Times and Statista.

This annual list highlights Europe’s most dynamic businesses – those showing exceptional growth and shaping their industries. We’re honoured to be included in the 2025 edition.

What is the FT1000?

The FT1000: Europe’s Fastest-Growing Companies is a respected ranking published by the Financial Times, based on revenue growth and innovation across sectors. The 2025 list is available on FT.com from 4 March, with full coverage in a Special Report released on 27 March 2025.

Being named in this ranking positions Revolve Healthcare among Europe’s leading innovators in healthtech and medical software.

What this recognition means

This recognition as a fastest-growing healthcare company in Europe reflects more than metrics. It highlights the results of long-term partnerships with healthcare organisations who trust us to deliver secure, compliant, and patient-centred software.

From custom medical software to certified SaMD solutions, we work with companies who aim to change the way care is delivered – across diagnostics, digital therapeutics, mental health, and connected health platforms.

Why it matters to our clients

Being featured in the FT1000 isn’t just a milestone for our team – it’s a signal of stability, expertise, and trust to our clients, partners, and collaborators. Whether you're a MedTech startup, a public health institution, or a healthtech scaleup preparing for certification – we’re here to support your next steps.

Looking ahead

As we grow our presence across Europe, we’re expanding our team, evolving our capabilities, and deepening collaborations with clients who prioritise regulatory compliance, user experience, and innovation.

If you're looking for a reliable partner in healthcare software development, let’s connect.

Category:

Tags:

You may also like